GlassScriptPhysician profile
Erika Sosa
NPI 1669942181
$8,030.35
in general payments reported to CMS, 2019-2025
32 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,034 · 2022: $1,619 · 2023: $3,073 · 2024: $1,243 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,316 · Travel and Lodging: $961 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,315.70 |
| Travel and Lodging | $961.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,759.62 | 2022-2025 | Venaseal, In.Pact Admiral, Percept PC Brainsense |
| Merck Sharp & Dohme LLC | $767.46 | 2021-2025 | Verquvo, Winrevair, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $687.48 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $651.11 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $579.58 | 2023 | Xarelto |
| Novo Nordisk INC | $436.65 | 2021-2023 | Ozempic |
| Amgen INC. | $406.95 | 2021-2025 | Repatha, Repatha |
| United Therapeutics Corporation | $290.52 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $289.73 | 2022-2023 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $258.35 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.39 | 2022-2023 | Jardiance |
| Esperion Therapeutics, INC. | $223.14 | 2021-2025 | Nexletol |
| Pfizer INC. | $171.80 | 2021-2025 | |
| Tactile Systems Technology INC | $164.99 | 2021-2025 | Flexitouch Plus, Nimbl |
| Atricure, INC. | $162.83 | 2021-2025 | Synergy Ablation System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $141.01 | 2021-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $120.01 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $114.47 | 2021-2025 | Farxiga, Wainua |
| Amarin Pharma, INC. | $103.92 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $94.03 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $74.71 | 2024-2025 | Amvuttra, Onpattro |
| Lilly USA, LLC | $64.25 | 2025 | Zepbound, Jardiance |
| Abbott Laboratories | $41.63 | 2022 | |
| Scpharmaceuticals INC. | $38.82 | 2023-2024 | |
| Boston Scientific Corporation | $29.41 | 2024 | Varithena Administration Pack |
| Kowa Pharmaceuticals America, INC. | $25.07 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $24.23 | 2024 | |
| Daiichi Sankyo INC. | $19.95 | 2023 | Injectafer |
| Angiodynamics, INC. | $17.32 | 2023 | Venacure 1470 Pro |
| Regeneron Healthcare Solutions, INC. | $15.64 | 2023 | Evkeeza |
| Organogenesis INC. | $14.15 | 2021 | |
| Irhythm Technologies, INC. | $13.13 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Sosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.